🔎 Trials Near Me

Akèy › Maladi Crohn › Illinois › Chicago

Etid klinik pou Maladi Crohn nan Chicago, IL

9 etid pou Maladi Crohn ap chèche patisipan nan sit nan ak bò kote Chicago (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Ap rekriteFaz 3
  • University of Chicago Medical Center ( Site 5066), Chicago
Laj 16 a 80 · Tout sèks · Mizajou Oct 2, 2026 · NCT06430801

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

Ap rekriteFaz 2
  • University of Chicago Medical Center /ID# 267400, Chicago
Laj 18 a 75 · Tout sèks · Mizajou Sep 25, 2026 · NCT06548542

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Ap rekriteFaz 3
  • Rush University Medical Center, Chicago
Laj 18 a 70 · Tout sèks · Mizajou Sep 24, 2026 · NCT06937099

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Ap rekriteFaz 3
  • Rush University Medical Center-Site Number: 8400015, Chicago
Laj 16 a 80 · Tout sèks · Mizajou Sep 23, 2026 · NCT07184931

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

Ap rekriteFaz 2
  • Rush University Medical Center, Chicago
Laj 18 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07483073

A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease

Ap rekriteFaz 2
  • Rush University Medical Center, Chicago
Laj 18 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07483099

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

Ap rekriteFaz 4
  • University of Chicago Medicine, Chicago
Laj 18 a 70 · Tout sèks · Mizajou Sep 9, 2026 · NCT06045754

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

Ap rekrite
  • University of Chicago Medicine, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Aug 7, 2026 · NCT05230173

Treatment of Moderate to Severe Refractory Crohn's Disease

Ap rekriteFaz 1/2
  • Northwestern, Chicago
  • University of Chicago, Chicago
Laj 18 a 65 · Tout sèks · Mizajou Dec 10, 2025 · NCT06721962

Etid Maladi Crohn nan lòt vil

Lòt etid nan Chicago

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.